| Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883) |
|---|
| 10/10/2002 | CA2442410A1 Duloxetine for treatment of hot flashes |
| 10/10/2002 | CA2442328A1 Therapeutic combinations for cardiovascular and inflammatory indications |
| 10/09/2002 | EP1246889A1 Method for desulphurizing thiopene derivatives contained in fuels |
| 10/09/2002 | EP1246820A1 Novel heteroaryl derivatives, their preparation and use |
| 10/09/2002 | EP1246803A1 Piperidine and piperazine derivatives which function as 5-ht 2a? receptor antagonists |
| 10/09/2002 | EP1246795A2 Antibacterial agents |
| 10/09/2002 | EP1246625A2 Methods and compositions for mitigating pain using nitrate esters |
| 10/09/2002 | CN1373754A Antibacterial agents |
| 10/09/2002 | CN1373750A 2'-substd. 1,1'-biphenyl-2-carbonamides, method for production thereof, use thereof as medicament and pharmaceutical preparation contg. said compounds |
| 10/09/2002 | CN1373660A Method for treating chronic pain using MEK inhibitors |
| 10/09/2002 | CN1092195C N-([1,2,4]triazoloazinyl]-benzenesulfonamide and pyridinesulfonamide compounds and their use as herbicides |
| 10/09/2002 | CN1092181C Benzyloxy substd, aromatics and their use as fungicides and insecticides |
| 10/08/2002 | USRE37873 Phenylacetic acid derivatives, preparation thereof and intermediates therefor, and compositions containing them |
| 10/08/2002 | US6462241 Process for preparing benzothiophenecarboxamide derivatives |
| 10/08/2002 | US6462198 Used in the control or prevention of acute and/or chronic neurological disorders such as restricted brain function caused by bypass operations or transplants, poor blood supply to the brain, spinal cord injuries, head injuries, hypoxia, |
| 10/08/2002 | US6462092 Such as 3-((3-fluorophenyl)-((3-(trifluoromethyl)phenyl)-methyl)amino)-1,1,1 -trifluoro-2-propanol; cardiovascular disease, i.e. atherosclerosis and other coronary artery diseases |
| 10/08/2002 | US6462076 Beta-amino acid nitrile derivatives as cathepsin K inhibitors |
| 10/08/2002 | US6462073 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 10/08/2002 | US6462057 Compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof |
| 10/08/2002 | US6462023 Cytostatic agents |
| 10/08/2002 | CA2216245C Preparation of cis-4-o-protected-2-cyclopentenol derivatives |
| 10/03/2002 | WO2002076964A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 10/03/2002 | WO2002076963A1 Bicyclic guanidine derivatives and therapeutic uses thereof |
| 10/03/2002 | WO2002076939A2 Cysteine protease inhibitors |
| 10/03/2002 | WO2002076929A1 Aryl and biaryl compounds having mch modulatory activity |
| 10/03/2002 | WO2002076926A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists |
| 10/03/2002 | WO2002076925A2 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses |
| 10/03/2002 | WO2002058631A3 Primary intermediates for oxidative coloration of hair |
| 10/03/2002 | US20020143186 For prophylaxis and therapy of hyperglycemia, Type 1 diabetes, Type 2 diabetes, disorders of the lipid metabolism, such as dyslipidemia, and obesity |
| 10/03/2002 | US20020143177 For inhibiting beta-secretase enzyme activity and A beta peptide production, inhibition of beta-secretase enzyme activity halts or reduces production of A beta from APP and reduces or eliminates the formation of beta-amyloid deposits |
| 10/03/2002 | US20020143054 Cyclopentane(ENE)heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents |
| 10/03/2002 | US20020143020 Novel piperazine derivatives |
| 10/03/2002 | US20020143004 Allosteric adenosine receptor modulators |
| 10/03/2002 | CA2441080A1 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses |
| 10/03/2002 | CA2436351A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists |
| 10/02/2002 | EP1244655A1 Antithrombotic agents |
| 10/02/2002 | EP1244617A1 Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone |
| 10/02/2002 | EP1244616A1 (hetero)bicyclylmethanesulfonylamino-substituted hydroxamic acid derivatives |
| 10/02/2002 | EP1244609A1 Preparing method of 2-phenylalkanoic acid derivatives |
| 10/02/2002 | EP1244436A2 Compounds and compositions for use in inhibiting endoparasitic fatty acid biosynthesis |
| 10/02/2002 | EP0877730B1 Aryl acrylics for use as fungicide |
| 10/02/2002 | DE10111936C1 N-Heteroarylmethyl-m-phenylendiamin-Derivate enthaltende Haarfärbemittel sowie neue N-Heteroarylmethyl-m-phenylendiamin-Derivate N-heteroarylmethyl-m-phenylenediamine derivatives, hair dyes containing as well as new N-heteroarylmethyl-m-phenylenediamine derivatives |
| 10/02/2002 | CN1372543A new vitamin derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments |
| 10/02/2002 | CN1372541A Sulfonyl carboxamide derivatives, method for their production and their use as medicaments |
| 10/02/2002 | CN1091770C Compounds useful as antiproliferative agents and GARFT inhibitors |
| 10/02/2002 | CN1091598C Pharmaceutical use of benzothiophene |
| 10/01/2002 | US6458982 Transition metal compound, catalyst, its production and its use for the polymerization of olefins |
| 10/01/2002 | US6458965 Herbicides, antigrowth agents and surfactants for wood preservatives |
| 10/01/2002 | US6458852 Use of substituted N, N-bis-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity |
| 10/01/2002 | US6458849 Method of treating or preventing a ceip-mediated disorder in a subject by administering a therapeutically effective amount of a compound for strokes |
| 10/01/2002 | US6458845 Macrophage scavenger receptor antagonists |
| 10/01/2002 | US6458811 Benzothiophenes formulations containing same and methods |
| 10/01/2002 | US6458805 Antagonists; especially sodium salts |
| 10/01/2002 | US6458803 Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity |
| 10/01/2002 | US6458779 Treatment of conditions associated with excess production of soluble cd23 (s-cd23) such as autoimmune disease and allergy. the compounds of the invention are also inhibitors of the release of tumour necrosis factor (tnf). |
| 09/26/2002 | WO2002074768A1 Piperazine derivatives, their preparation and uses in therapy (5ht1b receptor activity) |
| 09/26/2002 | WO2002074758A2 Novel amines as histamine-3 receptor ligands and their therapeutic applications |
| 09/26/2002 | WO2002074726A2 Aniline derivatives useful as phosphodiesterase 4 inhibitors |
| 09/26/2002 | WO2002074296A1 Remedies for solid cancer containing hydroxamic acid derivatives as the active ingredient |
| 09/26/2002 | WO2002074056A2 Allosteric adenosine receptor modulators |
| 09/26/2002 | WO2002046507A3 Onium salts and the use therof as latent acids |
| 09/26/2002 | WO2002044126A3 Bisubstituted carbocyclic cyclophilin binding compounds and theirus |
| 09/26/2002 | WO2002028810A3 Retinoids for the treatment of emphysema |
| 09/26/2002 | WO2002024636A3 N-acylsulfonamide apoptosis promoters |
| 09/26/2002 | WO2002004439A3 Thiophene retinoids |
| 09/26/2002 | WO2000071785A3 2-cylcoalkylcarbonylcyclohexane-1,3-dione derivatives as herbicides |
| 09/26/2002 | US20020137968 Treating with amides, ureas, amidines, carbamates, carboximidamides and other derivatives of given formula, e.g. (+)-N-((2,2-dimethylcyclopentyl)methyl)-4-hexyloxybenzamide |
| 09/26/2002 | US20020137961 Use as skin lightening agents; 4-(1,4-Dioxaspiro(4.5)dec-8-yl)-1,3-benzenediol for example |
| 09/26/2002 | US20020137947 Inhibits alpha v integrins; treating tumors or cancer |
| 09/26/2002 | US20020137939 Novel guanidinobenzamides |
| 09/26/2002 | US20020137750 Amidine derivatives which are inhibitors of nitric oxide synthase |
| 09/26/2002 | US20020137736 Novel compounds |
| 09/26/2002 | DE10112068A1 Use of sulfonylguanidine derivatives, mostly new compounds, for treating e.g. pain and neurodegeneration, have affinity for the gabapentin binding site |
| 09/26/2002 | DE10112041A1 p-Thienylbenzyl-Amide als Agonisten von Angiotensin-(1-7)-Rezeptoren, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate p-thienylbenzyl amides as agonists of angiotensin- (1-7) receptors, processes for their preparation, their use and pharmaceutical compositions containing them |
| 09/26/2002 | CA2441563A1 Allosteric adenosine receptor modulators |
| 09/26/2002 | CA2435847A1 Aniline derivatives useful as phosphodiesterase 4 inhibitors |
| 09/25/2002 | EP1243588A1 Stilbeneamine derivative and electrophotosensitive material using the same |
| 09/25/2002 | EP1242399A1 $g(a)-ARYLETHYLPIPERAZINE DERIVATIVES AS NEUROKININ ANTAGONISTS |
| 09/25/2002 | EP1242382A1 Tricyclic protein kinase inhibitors |
| 09/25/2002 | EP1242363A2 Cd45 inhibitors |
| 09/25/2002 | EP1012149B1 All-trans-retinol metabolite |
| 09/25/2002 | EP0975584B1 Synthesis and use of alpha-ketoamide derivatives and arrays |
| 09/25/2002 | EP0968179B1 N-sulphonyl and n-sulphinyl amino acid amides as microbiocides |
| 09/25/2002 | EP0841344B1 1-(2-deoxy-2-fluoro-4-thio-beta-d-arabinofuranosyl)cytosines |
| 09/24/2002 | US6455741 Process for preparing benzothiophenecarboxamide derivatives |
| 09/24/2002 | US6455581 Inhibitors of hiv protease. |
| 09/24/2002 | US6455573 Synthesizing salacinol, its stereoisomers, and non-naturally occurring selenium and nitrogen analogues thereof |
| 09/24/2002 | US6455545 Gastrointestinal disorders |
| 09/24/2002 | US6455520 Benzamide derivatives and their use as cytokine inhibitors |
| 09/24/2002 | US6455519 Use of substituted N, N-disubstituted fused-heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity |
| 09/24/2002 | US6455502 Compounds and compositions as protease inhibitors |
| 09/19/2002 | WO2002072569A1 P-thienylbenzyl-amides serving as agonists of angiotensin-(1-7)-receptors, method for the production thereof, their use and pharmaceutical preparations containing the same |
| 09/19/2002 | WO2002072568A1 N-heteroarylmethyl-m-phenylenediamine derivative-containing dyes for keratin fibers and novel n-heteroarylmethyl-m-phenylenediamine derivatives |
| 09/19/2002 | WO2002072524A2 Method for producing vinyl, aryl and heteroaryl acetic acids and derivatives thereof |
| 09/19/2002 | WO2002071827A2 Retinoid x receptor modulators |
| 09/19/2002 | WO2001007020A3 Carboxylic acid amides, medicaments containing these compounds and the use and production thereof |
| 09/19/2002 | US20020133025 Agriculture |
| 09/19/2002 | US20020132833 Caspase inhibitors and uses thereof |
| 09/19/2002 | US20020132818 Thienopyrimidines |
| 09/19/2002 | US20020132796 Treatment or prevention of the diseases and conditions which respond to treatment by retinoids and or which in healthy mammals, including humans, are controlled by natural retinoic acid. |